Related references
Note: Only part of the references are listed.Sister Mary Joseph's Nodule As a Diagnostic Clue to Metastatic Colon Carcinoma
Zhu Shen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Usha Menon et al.
LANCET ONCOLOGY (2009)
Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer
A. Prat et al.
ANNALS OF ONCOLOGY (2008)
Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer
Brenda B. J. Hermsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surveillance of women at high risk for hereditary ovarian cancer is inefficient
AL Oei et al.
BRITISH JOURNAL OF CANCER (2006)
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
MJ Duffy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
The effect of simple laparoscopic surgery on the serum level of the tumour marker CA 125
MJ Willett et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2004)
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations
DA Levine et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The significance of serum CA 125 elevation in malignant and nonmalignant diseases
K Sjövall et al.
GYNECOLOGIC ONCOLOGY (2002)
Share Paper
